Cancer is the world’s second leading cause of death. Every year, 10 million people die from cancer. Cancer kills 70% of people in low-to-middle-income countries. Cancer is estimated to cost the global economy USD 1.16 trillion per year. Millions of lives could be saved annually by implementing resource-appropriate prevention, early detection, and treatment strategies.
Every year leading goliaths operating in the oncology market, including Roche, AbbVie, Gilead Sciences, AstraZeneca, Merck, Astellas Pharma, and others, works hard to develop novel oncology drugs that would lower the burden on the patients. This year, the oncology drugs pipeline is also lo...
